Validation of the GeneXpert Xpress SARS-CoV-2 PCR assay using saliva as biological specimen
Open Access
- 1 March 2021
- journal article
- research article
- Published by Elsevier in The Brazilian Journal of Infectious Diseases
- Vol. 25 (2) , 101543
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Recommendations for sample pooling on the Cepheid GeneXpert® system using the Cepheid Xpert® Xpress SARS-CoV-2 assayPLOS ONE, 2020
- Brief validation of the novel GeneXpert Xpress SARS-CoV-2 PCR assayJournal of Virological Methods, 2020
- Saliva is a reliable, non-invasive specimen for SARS-CoV-2 detectionThe Brazilian Journal of Infectious Diseases, 2020
- Test Agreement between Roche Cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 Assays at High Cycle Threshold RangesJournal of Clinical Microbiology, 2020
- Saliva as an Alternate Specimen Source for Detection of SARS-CoV-2 in Symptomatic Patients Using Cepheid Xpert Xpress SARS-CoV-2Journal of Clinical Microbiology, 2020
- Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 TestJournal of Clinical Microbiology, 2020
- Saliva as a Noninvasive Specimen for Detection of SARS-CoV-2Journal of Clinical Microbiology, 2020
- Saliva is a reliable tool to detect SARS-CoV-2Journal of Infection, 2020
- Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCREurosurveillance, 2020